OPTIsoins01: Optimizing the Care Pathways of Patients Treated for Operable Breast.

Sponsor
Institut Curie (Other)
Overall Status
Completed
CT.gov ID
NCT02813317
Collaborator
(none)
617
9
28
68.6
2.4

Study Details

Study Description

Brief Summary

This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The treatment course of a breast cancer patient includes a hospital stay, home health care that requires outpatient services, supportive care and a follow-up course. Outpatient surgery and home hospitalization units are two innovative organizational technologies that are strongly recommended because of their putative positive medico-economic impact; however, these structures are poorly studied in terms of quality of care and patient satisfaction. Regional implementation of these innovations is heterogeneous, thus allowing a comparative study.

    This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.

    This study will be conducted in academic centers, general hospitals and private centers. In the different participating centers, the implemented care steps are different and may include outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care. Outpatient surgery and home hospitalization in particular are two health technologies that are validated by the French National Authority for Health but used differently in different centers.

    The primary objective is to examine the economic and financial measurements of the different care pathways of early breast cancer patients to compare the economic burden of outpatient surgery and home hospitalization with the conventional care pathway.

    The secondary objectives are:

    Assessing patient satisfaction and needs for supportive care. Evaluating the structures and organizations. Evaluating the tool exchanges between the actors over the treatment course.

    All parameters related to the patient and to disease characteristics, determinants and management characteristics within and outside the center within one year will be collected and centralized in the study database. The patients' course of care will be divided into five stages: preadmission, hospitalization, the postoperative period (+ 1 month), adjuvant treatments and one-year follow-up. Care pathways will be identified, described and analyzed to meet the primary objective and the secondary objectives.

    After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    617 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Optimizing the Care Pathways of Patients Treated for Operable Breast Cancer
    Actual Study Start Date :
    Dec 1, 2014
    Actual Primary Completion Date :
    Feb 1, 2017
    Actual Study Completion Date :
    Apr 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Care pathways description of early breast cancer patients. [Up to one year after patient registration]

      Care pathways will be characterized by the sequence of different care steps. Care steps may include : outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care.

    2. Overall cost measurements of the different care pathways. [Up to one year after patient registration]

      Evaluating the overall costs of the pathway care (health care and supportive care consumption) at one year for the different perspectives.

    3. Overall cost measurements of the different care pathways for health insurance [Up to one year after patient registration]

      Evaluating the indirect costs of health insurance

    4. Overall cost measurements of the different care pathways for the patient [Up to one year after patient registration]

      Evaluating the out-of-pocket health expenses for breast cancer during the first year post diagnosis (direct and indirect costs).

    Secondary Outcome Measures

    1. Patient satisfaction evaluation [Up to one year after patient registration.]

      Patient satisfaction will be assessed at different time points using the OUT-PATSAT35 questionnaire validated in French.

    2. Supportive care needs assessement [Up to one year after patient registration]

      The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey - Breast Cancer module (SCNS-BR8) validated in French.

    3. Supportive care needs assessement [Up to one year after patient registration]

      The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey Short Form (SCNS-SF34) validated in French.

    4. Breast cancer impact on patient's professional activity [Up to one year after patient registration.]

      Evaluating patient return to work : Existence of an occupational reintegration or not.

    5. Breast cancer impact on patient's professional activity [Up to one year after patient registration.]

      Evaluating patient return to work : Date of return to work

    6. Breast cancer impact on patient's professional activity [Up to one year after patient registration.]

      Evaluating patient return to work : Organization of working time description

    7. Breast cancer impact on patient's professional activity [Up to one year after patient registration.]

      Evaluating patient return to work : Number of days out of work

    8. Structures and organizations interactions description [Up to one year after patient registration]

      Identification of health care actors inside and outside the hospital

    9. Structures and organizations interactions description [Up to one year after patient registration]

      identification of the interactions between the organizations (e.g., identification, shared tools, resource sharing and nurse training).

    10. Structures and organizations interactions description [Up to one year after patient registration]

      Regular practitioners questionnaires

    Other Outcome Measures

    1. Care pathways suggestion for a regional health territory. [Through study completion (within one year after the last patient follow-up)]

      After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Signed written informed consent.

    2. Patients aged ≥18 years.

    3. Previously untreated, operable breast cancer

    4. Affiliation with the social security system (or a similar coverage)

    5. Patient living in one of these french department : "Hauts-de-Seine (92)", "les Yvelines (78)", or "le Val d'Oise (95)".

    6. Female gender.

    Exclusion Criteria:
    1. Previous history of breast cancer.

    2. Metastatic, locally advanced, or inflammatory breast cancer, as defined by the AJCC (American Joint Committee on Cancer, 7th Edition).

    3. Any prior treatment for primary breast cancer.

    4. Patient with any psychological, sociological or geographical condition potentially hampering compliance with the study follow-up schedule.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Victor Dupouy Hospital Argenteuil France 95100
    2 Antoine Béclère Hospital Clamart France
    3 Louis Mourier Hospital Colombes France 92700
    4 André Mignot Hospital - Versailles Le Chesnay France 78150
    5 Institut Curie Paris France 75005
    6 Bichat Beaujon University Hospital Paris France 75018
    7 Poissy Interegional Hospital Center Poissy France 78300
    8 René Dubos Hospital Pontoise France 95000
    9 Institut Curie - René Huguenin Hospital Saint-Cloud France 92210

    Sponsors and Collaborators

    • Institut Curie

    Investigators

    • Study Director: Roman ROUZIER, Pr, Institut Curie
    • Study Director: Delphine HEQUET, MD PhD, Institut Curie

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Institut Curie
    ClinicalTrials.gov Identifier:
    NCT02813317
    Other Study ID Numbers:
    • IC 2014-11
    First Posted:
    Jun 27, 2016
    Last Update Posted:
    Apr 13, 2017
    Last Verified:
    Apr 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Institut Curie
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 13, 2017